Biomed Central Ltd

SHERPA: Unknown

People

  1. Hirschhorn Cymerman
    Hirschhorn Cymerman
  2. Budhu
    Budhu
  3. Liu
    Liu
  4. Mangarin
    Mangarin
  5. Zhong
    Zhong
  6. Panageas
    Panageas
  7. Yang
    Yang
  8. George
    George
  9. Holland
    Holland
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Melanoma and Immunotherapeutics Service (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematology-Oncology Fellows (4)
  7. Thoracic Oncology (3)
  8. Biostatistics Service (2)
  9. Dermatology Service (2)
  10. Dermatology (2)
Search Within
  1. "Daniel Hirschhorn Cymerman"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Melanoma and Immunotherapeutics Service (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematology-Oncology Fellows (4)

More Groups

People
  1. Daniel Hirschhorn Cymerman (6)
  2. Jedd Wolchok (6)
  3. Taha Merghoub (6)
  4. Sadna Budhu (5)
  5. Billel Gasmi (4)
  6. Cailian Liu (4)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save